Vaccination with Rev and Tat against AIDS

被引：94

作者：

Osterhaus, ADME

van Baalen, CA

Gruters, RA

Schutten, M

Siebelink, CHJ

Hulskotte, EGJ

Tijhaar, EJ

Randall, RER

van Amerongen, G

Fleuchaus, A

Erfle, V

Sutter, G

机构：

[1] Eramus Med Ctr Rotterdam, NL-3015 GE Rotterdam, Netherlands

[2] Ecole Normale Super Lyon, UMR103, CNRS Biomerieux, F-69364 Lyon 07, France

[3] Univ St Andrews, Sch Biomed Sci, St Andrews KY16 9ST, Fife, Scotland

[4] GSF, Inst Mol Virol, D-85764 Neurenberg, Germany

来源：

VACCINE | 1999年 / 17卷 / 20-21期

关键词：

D O I：

10.1016/S0264-410X(98)00498-8

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：2713 / 2714

页数：2

共 8 条

[1] The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate
Conley, AJ
Kessler, JA
Boots, LJ
McKenna, PM
Schleif, WA
Emini, EA
Mark, GE
Katinger, H
Cobb, EK
Lunceford, SM
Rouse, SR
Murthy, KK
[J]. JOURNAL OF VIROLOGY, 1996, 70 (10) : 6751 - 6758
[2] Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1
Gauduin, MC
Parren, PWHI
Weir, R
Barbas, CF
Burton, DR
Koup, RA
[J]. NATURE MEDICINE, 1997, 3 (12) : 1389 - 1393
[3] Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines
Graham, BS
McElrath, MJ
Connor, RI
Schwartz, DH
Gorse, GJ
Keefer, MC
Mulligan, MJ
Matthews, TJ
Wolinsky, SM
Montefiori, DC
Vermund, SH
Lambert, JS
Corey, L
Belshe, RB
Dolin, R
Wright, PF
Korber, BT
Wolff, MC
Fast, PE
[J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (02) : 310 - 319
[4] VACCINE-INDUCED VIRUS-NEUTRALIZING ANTIBODIES AND CYTOTOXIC T-CELLS DO NOT PROTECT MACAQUES FROM EXPERIMENTAL-INFECTION WITH SIMIAN IMMUNODEFICIENCY VIRUS SIVMAC32H (J5)
HULSKOTTE, EGJ
GERETTI, AM
SIEBELINK, KHJ
VANAMERONGEN, G
CRANAGE, MP
RUD, EW
NORLEY, SG
DEVRIES, P
OSTERHAUS, ADME
[J]. JOURNAL OF VIROLOGY, 1995, 69 (10) : 6289 - 6296
[5] Progress in the development of an HIV-1 vaccine
Letvin, NL
[J]. SCIENCE, 1998, 280 (5371) : 1875 - 1880
[6] VIRIONS OF PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES RESISTANT TO SOLUBLE CD4 (SCD4) NEUTRALIZATION DIFFER IN SCD4 BINDING AND GLYCOPROTEIN GP120 RETENTION FROM SCD4-SENSITIVE ISOLATES
MOORE, JP
MCKEATING, JA
HUANG, YX
ASHKENAZI, A
HO, DD
[J]. JOURNAL OF VIROLOGY, 1992, 66 (01) : 235 - 243
[7] Kinetics of antiviral activity by human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL) and rapid selection of CTL escape virus in vitro
Van Baalen, CA
Schutten, M
Huisman, RC
Boers, PHM
Gruters, RA
Osterhaus, ADME
[J]. JOURNAL OF VIROLOGY, 1998, 72 (08) : 6851 - 6857
[8] Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS
vanBaalen, CA
Pontesilli, O
Huisman, RC
Geretti, AM
Klein, MR
deWolf, F
Miedema, F
Gruters, RA
Osterhaus, ADME
[J]. JOURNAL OF GENERAL VIROLOGY, 1997, 78 : 1913 - 1918

← 1 →